{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:24:42Z","timestamp":1792805082190,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.radonc.2023.109817","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T13:04:29Z","timestamp":1689858269000},"page":"109817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Reirradiation with stereotactic body radiotherapy for primary or secondary lung malignancies: Tumor control probability and safety analyses"],"prefix":"10.1016","volume":"187","author":[{"given":"Huan-Huan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas G","family":"Zaorsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Min","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Zhi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Sheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Bin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109817_b0005","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2023.109817_b0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41571-020-00432-6","article-title":"Lung cancer LDCT screening and mortality reduction-evidence, pitfalls and future perspectives","volume":"18","author":"Oudkerk","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0015","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines): non-small cell lung cancer. Version 1.2022. Accessed August 24, 2022. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nscl.pdf."},{"key":"10.1016\/j.radonc.2023.109817_b0020","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomized trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0025","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.radonc.2018.02.016","article-title":"Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy","volume":"127","author":"Klement","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0030","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ijrobp.2015.07.2278","article-title":"Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 Non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG0403","volume":"93","author":"Nagata","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109817_b0035","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S1470-2045(21)00401-0","article-title":"Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery","volume":"22","author":"Chang","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0040","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jtho.2021.04.002","article-title":"Stereotactic radiation for lung cancer: a practical approach to challenging scenarios","volume":"16","author":"Andruska","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0045","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ctrv.2016.10.002","article-title":"Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: A critical literature review of predictive factors of relapse","volume":"50","author":"Loganadane","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2023.109817_b0050","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S1470-2045(12)70242-5","article-title":"Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis","volume":"13","author":"Senthi","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0055","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1111\/cas.14185","article-title":"Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer","volume":"110","author":"Meng","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.radonc.2023.109817_b0060","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1200\/JCO.2001.19.4.1056","article-title":"Second cancers occurring in patients with early stage non-small-cell lung cancer treated with chest radiation therapy alone","volume":"19","author":"Jeremic","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0065","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/JTO.0000000000000576","article-title":"Patterns of disease recurrence after SABR for early stage non-small-cell lung cancer: optimizing follow-up schedules for salvage therapy","volume":"10","author":"Verstegen","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0070","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","article-title":"Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document","volume":"148","author":"Lievens","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0080","doi-asserted-by":"crossref","first-page":"e181390","DOI":"10.1001\/jamanetworkopen.2018.1390","article-title":"Association of long-term outcomes and survival with multidisciplinary salvage treatment for local and regional recurrence after stereotactic ablative radiotherapy for early-stage lung cancer","volume":"1","author":"Brooks","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.radonc.2023.109817_b0085","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1097\/JTO.0b013e3181f260f9","article-title":"Salvage lung resection for non-small cell lung cancer after stereotactic body radiotherapy in initially operable patients","volume":"5","author":"Chen","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0090","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jtho.2016.10.018","article-title":"Multi-institutional prospective study of reirradiation with proton beam radiotherapy for locoregionally recurrent non-small cell lung cancer","volume":"12","author":"Chao","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0095","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.radonc.2018.10.017","article-title":"Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis","volume":"132","author":"Kann","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0100","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4103\/0973-1482.126481","article-title":"Repeat stereotactic body radiation therapy for patients with pulmonary malignancies who had previously received SBRT to the same or an adjacent tumor site","volume":"9","author":"Valakh","year":"2013","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.radonc.2023.109817_b0105","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.radonc.2013.03.015","article-title":"Reirradiation and stereotactic radiotherapy for tumors in the lung: dose summation and toxicity","volume":"107","author":"Meijneke","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0110","doi-asserted-by":"crossref","first-page":"S643","DOI":"10.1016\/j.ijrobp.2014.05.1905","article-title":"Re-stereotactic body radiation therapy (SBRT) for local recurrence of lung cancer previously treated with SBRT","volume":"90","author":"Nonaka","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109817_b0115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5430\/jst.v4n2p4","article-title":"Evaluating patterns of failure and salvage therapy for patients treated with primary stereotactic body radiation therapy for early stage non-small cell lung cancer","volume":"4","author":"Mezera","year":"2014","journal-title":"J Solid Tumors"},{"key":"10.1016\/j.radonc.2023.109817_b0120","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijrobp.2014.05.048","article-title":"Salvage stereotactic body radiation therapy (SBRT) for local failure after primary lung SBRT","volume":"90","author":"Hearn","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109817_b0125","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1097\/JTO.0000000000000543","article-title":"Dose-Escalated Stereotactic body radiotherapy (SBRT) as a salvage treatment for two cases with relapsed peripheral lung cancer after initial SBRT","volume":"10","author":"Nishimura","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13014-018-1041-y","article-title":"Re-irradiation in lung disease by SBRT: a retrospective, single institutional study","volume":"13","author":"Caivano","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0135","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13014-018-1080-4","article-title":"Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT","volume":"13","author":"Ogawa","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.radonc.2019.08.010","article-title":"Repeat stereotactic body radiation therapy (SBRT) for salvage of isolated local recurrence after definitive lung SBRT","volume":"142","author":"Kennedy","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0145","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1038\/s41598-021-83210-3","article-title":"In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO)","volume":"11","author":"John","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2023.109817_b0150","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.radonc.2011.09.012","article-title":"Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy","volume":"101","author":"Peulen","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0155","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0167-8140(83)80021-8","article-title":"A new isoeffect curve for change in dose per fraction","volume":"1","author":"Withers","year":"1983","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0160","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijrobp.2020.11.021","article-title":"Stereotactic body radiation therapy for spinal metastases: tumor control probability analyses and recommended reporting standards","volume":"110","author":"Soltys","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109817_b0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2020.11.020","article-title":"A primer on dose-response data modeling in radiation therapy","volume":"110","author":"Moiseenko","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109817_b0170","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.radonc.2013.06.047","article-title":"High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer","volume":"109","author":"Huang","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0175","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijrobp.2016.04.003","article-title":"Validation of high-risk computed tomography features for detection of local recurrence after Stereotactic body radiation therapy for early-stage non-small cell lung cancer","volume":"96","author":"Peulen","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109817_b0180","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0022-5223(19)40289-4","article-title":"Multiple primary lung cancers","volume":"70","author":"Martini","year":"1975","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.radonc.2023.109817_b0185","doi-asserted-by":"crossref","unstructured":"Ronden MI, van Sornsen de Koste JR, Johnson C, Slotman BJ, Spoelstra FOB, et al. Incidence of high-risk radiologic features in patients without local recurrence after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2018; 100: 115-121.","DOI":"10.1016\/j.ijrobp.2017.09.035"},{"key":"10.1016\/j.radonc.2023.109817_b0190","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.ijrobp.2011.10.035","article-title":"Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer","volume":"83","author":"Zhang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109817_b0195","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamaoncol.2018.1258","article-title":"Long-term results of stereotactic body radiation therapy in medically inoperable stage I non-small cell lung cancer","volume":"4","author":"Timmerman","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0200","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located Non-small-cell lung cancer: NRG Oncology\/RTOG 0813 Trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0205","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ctrv.2013.03.007","article-title":"Review of current thermal ablation treatment for lung cancer and the potential of electrochemotherapy as a means for treatment of lung tumors","volume":"39","author":"Jahangeer","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2023.109817_b0210","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00000421-199312000-00004","article-title":"The reirradiation of recurrent bronchogenic carcinoma with external beam irradiation","volume":"16","author":"Montebello","year":"1993","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0215","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00000421-200004000-00011","article-title":"Thoracic reirradiation for symptomatic relief after prior radiotherapeutic management for lung cancer","volume":"23","author":"Gressen","year":"2000","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0220","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/COC.0000000000000709","article-title":"Effectiveness and Safety of Reirradiation with stereotactic ablative radiotherapy of lung cancer after a first course of thoracic radiation: A Meta-analysis","volume":"43","author":"Viani","year":"2020","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0225","doi-asserted-by":"crossref","first-page":"e620","DOI":"10.1016\/S1470-2045(14)70345-6","article-title":"High-dose re-irradiation following radical radiotherapy for non-small-cell lung cancer","volume":"15","author":"De Ruysscher","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0230","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ctrv.2015.04.002","article-title":"Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies","volume":"41","author":"De Bari","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2023.109817_b0235","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.prro.2018.01.008","article-title":"Review of thoracic reirradiation with stereotactic body radiation therapy: A focus on toxicity risks","volume":"8","author":"Milano","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0240","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy Vs. maintenance therapy or observation for patients with oligometastatic Non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0245","doi-asserted-by":"crossref","first-page":"e173501","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic Non-small-cell lung cancer: a phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0250","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomized, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2023.109817_b0255","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejca.2017.12.012","article-title":"Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group","volume":"91","author":"deSouza","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2023.109817_b0260","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ijrobp.2009.09.070","article-title":"Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation","volume":"78","author":"Kelly","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109817_b0265","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ijrobp.2012.02.020","article-title":"Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy","volume":"84","author":"Liu","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109817_b0270","doi-asserted-by":"crossref","first-page":"868844","DOI":"10.3389\/fonc.2022.868844","article-title":"Safety and efficacy of stereotactic ablative radiotherapy for ultra-central lung cancer","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0275","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0280","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jtho.2021.03.019","article-title":"The HILUS-Trial-a prospective nordic multicenter phase 2 study of ultracentral lung tumors treated with stereotactic body radiotherapy","volume":"16","author":"Lindberg","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0285","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13014-017-0897-6","article-title":"Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation","volume":"12","author":"Repka","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0290","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00066-010-2072-y","article-title":"Stereotactic body radiotherapy for lung tumors at the pulmonary hilum","volume":"186","author":"Oshiro","year":"2010","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2023.109817_b0295","doi-asserted-by":"crossref","first-page":"S495","DOI":"10.1016\/j.ijrobp.2010.07.1160","article-title":"Reirradiation with a second course of stereotactic body radiotherapy for locally recurrent lung lesions","volume":"78","author":"Bylund","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109817_b0300","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.ijrobp.2014.01.012","article-title":"Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer","volume":"88","author":"Trovo","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109817_b0305","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.radonc.2013.11.017","article-title":"Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment","volume":"110","author":"Kilburn","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0310","doi-asserted-by":"crossref","first-page":"S640","DOI":"10.1016\/j.ijrobp.2014.05.1898","article-title":"An evaluation of toxicity using accumulated total dose based on EQD2 for thoracic reirradiation incorporating at least 1 course of SBRT","volume":"90","author":"Lester","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109817_b0315","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13256-017-1504-z","article-title":"Serious gastric perforation after second stereotactic body radiotherapy for peripheral lung cancer that recurred after initial stereotactic body radiotherapy: a case report","volume":"11","author":"Nonaka","year":"2017","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.radonc.2023.109817_b0320","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12885-019-5542-3","article-title":"Long-term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer","volume":"19","author":"Sumodhee","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2023.109817_b0325","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.radonc.2020.07.033","article-title":"Re-irradiation in the thorax-An analysis of efficacy and safety based on accumulated EQD2 doses","volume":"152","author":"Schr\u00f6der","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0330","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12885-020-06906-1","article-title":"Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases","volume":"20","author":"Berkovic","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2023.109817_b0335","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cllc.2020.06.006","article-title":"Clinical Outcomes and Predictors of Lung Toxicity After Multiple Courses of Lung Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer","volume":"22","author":"Muller","year":"2021","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.radonc.2023.109817_b0340","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3390\/curroncol28030170","article-title":"Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective Analysis","volume":"28","author":"Grambozov","year":"2021","journal-title":"Curr Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0345","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s13566-014-0175-2","article-title":"Stereotactic body radiotherapy for re-irradiation of lung cancer recurrence with lower biological effective doses","volume":"4","author":"Patel","year":"2015","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109817_b0350","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijrobp.2020.01.018","article-title":"To biopsy or not to biopsy? A matched cohort analysis of early-stage lung cancer treated with stereotactic radiation with or without histologic confirmation","volume":"107","author":"Dautruche","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109817_b0355","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijrobp.2005.11.028","article-title":"Stereotactic body radiation therapy for nonmetastatic lung cancer: an analysis of 75 patients treated over 5 years","volume":"65","author":"Beitler","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402300378X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402300378X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:26:45Z","timestamp":1759123605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402300378X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":71,"alternative-id":["S016781402300378X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109817","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reirradiation with stereotactic body radiotherapy for primary or secondary lung malignancies: Tumor control probability and safety analyses","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109817"}}